BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Extract Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NELSON, J D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NELSON, J D.
Topic Collections
Right arrowRelevant Article
Br J Ophthalmol 1999;83:384-385 ( April )

Editorial

Much more than water

The belief that the tear film is aqueous based and the ocular surface changes seen in Sjögren's syndrome are due to desiccation, cause eye care practitioners to water the dry eye. Studies show the tear film is dominated by mucin and not water.1 2 It is not a 7-10 µm thin film, but a 30-35 µm thick mucin gel. Bicarbonate may be critical to forming this gel as it is in forming the bicarbonate mucin gel that protects the stomach from autodigestion.3 The hallmark of the aqueous deficient dry eye, rose bengal staining of the conjunctiva, is not produced by desiccated cells, but is due to a deficiency in the protective mucin gel.4

The first major innovation in the treatment of the dry eye seen in Sjögren's syndrome was the introduction of preservative-free artificial tears. Although the absence of preservatives allowed frequent topical application, the improvement seen in these severe dry eyes was more the result of the elimination of toxic preservatives than increased frequency of use. Preservative-free artificial tears allowed for more frequent watering of the dry eye, but watering alone does not reverse the ocular surface changes seen in Sjögren's syndrome.

The ocular surface changes include conjunctival squamous metaplasia, loss of integrity of cell membranes and junctional structures (fluorescein staining), and loss of the integrity of the mucin layer (rose bengal staining). Rose bengal staining and squamous metaplasia are not improved by the frequent application of non-preserved preparations.5 Bicarbonate and electrolyte solutions promote recovery of barrier function and ultrastructure in damaged ocular surface cells6 and increase corneal glycogen and goblet cell density.7 These solutions, however, do not totally reverse ocular surface disease seen in Sjögren's syndrome. Even with the addition of electrolytes and bicarbonate to artificial tears, watering the dry eye is not enough.

In this issue of the journal, Tsubota and colleagues (p 390) demonstrate that the application of autologous serum improved fluorescein and rose bengal scores and squamous metaplasia. It also resulted in significant upregulation of MUC-1 in conjunctival epithelial cell cultures. The authors speculate that the epidermal growth factor (EGF), vitamin A, and transforming growth factor beta  (TGF-beta ) found in serum represent critical components missing from the tears of patients with Sjögren's syndrome.

Certain cytokines may play an important role in the regulation of proliferation, differentiation, and maturation of the ocular surface epithelium. Other cytokines may prove harmful.8 Experimental studies demonstrate that EGF9 10 and hepatocyte growth factor (HGF),11 12 which are present in human tears and secreted by the lacrimal gland, are important in corneal wound healing. Both also increase as aqueous tear production increases. TGF-alpha 13 and TGF-beta 14 are found in human tears. Both are probably involved in corneal epithelial cell growth and differentiation.15 Retinol, also secreted by the lacrimal gland and found in the tear film, is necessary for the maintenance of healthy ocular surface epithelium.16 Not only may the tear film of patients with Sjögren's syndrome be missing critical components, tears may actually contain substances that lead to ocular surface injury. Cytokines may be produced in or by the lacrimal gland in response to inflammation. These factors, delivered to the ocular surface by the tear fluid, may lead to inflammation of the ocular surface. mRNA for interleukins IL-1 and IL-6 has been detected in the lacrimal glands of autoimmune female MRL/lpr mice.17 Increased levels of IL-1 induce keratocyte apoptosis18 and metalloproteinases.19 IL-6 induces lymphocytic differentiation.

In Sjögren's syndrome, reflex tearing decreases with increased lymphocytic infiltration of the lacrimal gland.20 Reflex tearing flushes debris from the ocular surface, dilutes substances in the tear film, and delivers higher amounts of certain cytokines to the ocular surface. The loss of reflex tearing results in reduced tear clearance causing prolonged retention of substances in the tear film.21 It is likely that the loss of reflex tearing also results in the lack of delivery of cytokines and retinol critical to the growth and differentiation of ocular surface epithelial cells.

The upregulation of MUC-1 suggests there are substances in serum which promote reformation of the mucin gel and, therefore, resolution of rose bengal staining. Similar substances, that are important in the maintenance of the mucin gel, are probably missing in the Sjögren's dry eye.

The use of serum tears is not new.22 However, Tsubota and colleagues show it is what is in tears that counts. The presence of cytokines and retinol are critical for the growth, differentiation, and wound healing of the ocular surface. Artificial tears flush out debris, dilute substances trapped in the tear film, and increase tear clearance. They do not, however, provide all the factors critical for the maintenance and repair of the ocular surface. That the application of serum tears reverses the ocular surface changes in Sjögren's syndrome should open the door to new therapies as well as reinforce the fact that tears are much more than water.

J DANIEL NELSON
Health Partners Research Foundation and the Departments of Ophthalmology, HealthPartners Medical Group Regions Hospital, 640 Jackson Street, St Paul, MN 55101, USA and the University of Minnesota, Minneapolis, Minnesota, USA

References

1. Prydal JI, Artal P, Woon H, et al. Study of human precorneal tear film thickness and structure using laser interferometry. Invest Ophthalmol Vis Sci 1992;33:2006-2011[Abstract/Free Full Text].
2. Prydal J, Campbell F. Study of precorneal fluid thickness and structure by interferometry and confocal microscopy. Invest Ophthalmol Vis Sci 1992;33:1996-2005[Abstract/Free Full Text].
3. Slomiany BL, Slomiany A. Role of mucus in gastric mucosal protection. J Physiol Pharmacol 1991;42:147-161[Medline].
4. Feenstra RPG, Tseng SCG. What is actually stained by rose bengal? Arch Ophthalmol 1992;110:984-993[Abstract].
5. Nelson JD, Gordon JF. Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron keratoconjunctivitis sicca study group. Am J Ophthalmol 1992;114:441-447[Medline].
6. Ubels J, McCartney M, Lantz W, et al. Effects of preservative-free artificial tear solutions on corneal epithelial structure and function. Arch Ophthalmol 1995;113:371-378[Abstract].
7. Gilbard JP, Rossi SR. An electrolyte-based solution that increases corneal glycogen and conjunctival goblet-cell density in a rabbit model for keratoconjunctivitis sicca. Ophthalmology 1992;99:600-604[Medline].
8. Nelson J. A clinician looks at the tear film. Adv Exp Med Biol 1998;438:1-9[Medline].
9. Van Setten G. Epidermal growth factor in human tear fluid: increased release but decreased concentrations during reflex tearing. Curr Eye Res 1990;9:79-83[Medline].
10. Kiatazawa T, Kinoshita S, Fujita K, et al. The mechanism of accelerated corneal epithelial healing by human epidermal growth factor. Invest Ophthalmol Vis Sci 1990;31:1773-1778[Abstract/Free Full Text].
11. Ii Q, Weng J, Mohan R, et al. Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal glands, tears, and cornea. Invest Ophthalmol Vis Sci 1996;37:727-739[Abstract/Free Full Text].
12. Tervo T, Vesaluuoma M, Bennett G, et al. Tear hepatocyte growth factor (HGF) availability increases markedly after excimer laser surface ablation. Exp Eye Res 1997;64:501-504[Medline].
13. Van Sletten G, Macauley S, Humphreys-Beher M, et al. Detection of transforming growth factor-alpha mRNA in rat lacrimal glands and characterization of transforming growth factor-alpha in human tears. Invest Ophthalmol Vis Sci 1996;37:166-173[Abstract/Free Full Text].
14. Yoshino K, Rahul G, Monroy D, et al. Production and secretion of transforming growth factor beta (TGF-beta ) by the human lacrimal gland. Curr Eye Res 1996;15:615-624[Medline].
15. Sotozono C, Kinoshita S. Growth factors and cytokines in corneal wound healing. In: Nishida T, ed. Proceedings: corneal healing responses to injuries and refractive surgeries. Amsterdam: Kugler Publications, 1998;29-38.
16. Ubels J, Loley K, Rismondo V. Retinol secretion by the lacrimal gland. Invest Ophthalmol Vis Sci 1986;27:1261-1269[Abstract/Free Full Text].
17. Ono M, Huang Z, Wickam L, et al. Analysis of androgen receptors and cytokines in lacrimal glands of a mouse model of Sjögren's syndrome. Invest Ophthalmol Vis Sci 1994;35:S1793.
18. Wilson S, He Y, Weng J, et al. Epithelial injury induces keratocyte apoptosis: hypothesized role for interleukin-1 system in modulation of corneal tissue organization wound healing. Exp Eye Res 1996;62:325-327[Medline].
19. Girard M, Matsubara M, Fine M. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression in corneal stromal cells. Invest Ophthalmol Vis Sci 1991;31:2441-2454.
20. Tsubota K, Xu K, Fujihara T, et al. Decreased reflex tearing is associated with lymphocytic infiltration in lacrimal glands. J Rheum 1996;23:313-320[Medline].
21. Barton K, Monroy D, Nava A, et al. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology 1997;104:1868-1874[Medline].
22. Fox R, Chan R, Michelson J, et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984;27:459-461[Medline].


© 1999 by British Journal of Ophthalmology

Relevant Article

Treatment of dry eye by autologous serum application in Sjögren's syndrome
Kazuo Tsubota, Eiki Goto, Hiromi Fujita, Masafumi Ono, Hiroko Inoue, Ichiro Saito, and Shigeto Shimmura
Br. J. Ophthalmol. 1999 83: 390-395. [Abstract] [Full Text] [PDF]




This Article
Right arrow Extract Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NELSON, J D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NELSON, J D.
Topic Collections
Right arrowRelevant Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 by the BMJ Publishing Group Ltd.